Morphine-6β-glucuronide-induced hyperphagia: Characterization of opioid action by selective antagonists and antisense mapping in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 538-544

  Leventhal, Liza ^a   Silva, Robert M ^a   Rossi, Grace C ^b   Pasternak, Gavril W ^b   Bodnar, Richard J ^a,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA FUNALTREXAMINE; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NOCICEPTIN; OPIATE ANTAGONIST; ANTISENSE OLIGONUCLEOTIDE; MORPHINE DERIVATIVE; MORPHINE-6-GLUCURONIDE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXON; GENE MAPPING; GENE SEQUENCE; HYPERPHAGIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR SENSITIVITY; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG POTENTIATION; NUCLEOTIDE SEQUENCE; SPRAGUE DAWLEY RAT;

ANIMALS; BASE SEQUENCE; HYPERPHAGIA; MORPHINE DERIVATIVES; OLIGONUCLEOTIDES, ANTISENSE; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 0032219601     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Abbott FV and Palmour RM (1988) Morphine-6β-glucuronide: Analgesic effects and receptor binding profile in rats. Life Sci 43:1685-1695.
2. Bodnar RJ (1996) Opioid receptor subtype antagonists and ingestion, in Drug Receptor Subtypes and Ingestive Behaviour, pp 127-146, Academic Press, London.
3. Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A and Pasternak GW (1997a): 3-Methoxy-naltrexone, a selective heroin/morphine-6β-glucuronide antagonist. FEBS Lett 412:35-38.
4. 3H-morphine-6β-glucuronide binding in brain membranes and MOR-1-transfected cell line. J Pharmacol Exp Ther 282:1291-1297.
5. Chien CC, Brown GP, Pan YX and Pasternak GW (1994): Blockade of U50488H analgesia by antisense oligodeoxynucleotides to a kappa opioid receptor. Eur J Pharmacol 253:R7-8.
6. Frances B, Gout R, Monsarrat B, Cros J and Zajac J (1992): Further evidence that morphine-6β-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ther 262:25-31.
7. Gosnell BA and Levine AS (1996): Stimulation of ingestive behaviour by preferential and selective opioid agonists, in Drug Receptor Subtypes and Ingestive Behaviour, pp 147-166, Academic Press, London.
8. Jaffe JH and Martin WR (1985): Opioid analgesics and antagonists, in The Pharmacological Basis of Therapeutics, pp 491-532, MacMillan, New York.
9. Leventhal L, Cole JL, Rossi GC, Pan YX, Pasternak GW and Bodnar RJ (1996) Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats. Brain Res 719:78-84.
10. Leventhal L, Mathis JP, Rossi GC, Pasternak GW and Bodnar RJ (1998): Orphan opioid receptor antisense probes block orphanin-induced hyperphagia. Eur J Pharmacol 349:R1-R3.
11. Leventhal L, Stevens LB, Rossi GC, Pasternak GW and Bodnar RJ (1997): Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO. J Pharmacol Exp Ther 282:1402-1407.
12. Levine AS, Grace M, Billington CJ and Portoghese PS (1990): Nor-binaltorphamine decreases deprivation and opioid-induced feeding. Brain Res 534:60-64.
13. Levine AS, Grace M and Billington CJ (1991): β-funaltrexamine (β-FNA) decreases deprivation and opioid-induced feeding. Brain Res 562:281-284.
14. Levine AS, Grace M, Portoghese PS and Billington CJ (1994): The effect of selective opioid antagonists on butorphanol-induced feeding. Brain Res 637:242-248.
15. Levine AS and Morley JE (1983): Butorphenol tartrate induces feeding in rats. Life Sci 32:781-785.
16. Meunier JC, Mollereau C, Toll L, Suadeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazagull H, Vassart G, Parmentier M and Constentin J (1995): Isolation and structure of the endogenous agonist of the opioid receptor-like ORL1 receptor. Nature 377:532-535.
17. Morley JE, Levine AS, Yim GKW and Lowy MT (1983): Opioid modulation of appetite. Neurosci Biobehav Rev 7:281-305.
18. Pan YX, Cheng J, Xu J, Rossi G, Jacobson E, Ryan-Moro J, Brooks AI, Dean GE, Standifer KM and Pasternak GW (1995) Cloning and functional characterization through antisense mapping of a kappa3-related opioid receptor. Mol Pharmacol 47:1180-1188.
19. Pasternak GW, Bodnar RJ, Clark JA and Inturrisi CE (1987): Morphine-6β-glucuronide, a potent mu agonist. Life Sci 41:2845-2849.
20. Pasternak GW and Standifer KM (1995): Mapping of opioid receptors using antisense oligodeoxynucleotides: Correlating their molecular biology and pharmacology. Trends Pharmacol Sci 16:344-350.
21. Paul D, Standifer KM, Inturrisi CE and Pasternak GW (1989): Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 251:477-483.
22. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ and Civelli O (1995): Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792-794.
23. Rossi GC, Brown GP, Leventhal L, Yang K and Pasternak GW (1996): Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci Lett 216:1-4.
24. Rossi GC, Leventhal L, Pan Y-X, Cole J, Su W, Bodnar RJ and Pasternak GW (1997a): Differential inhibition of morphine and morphine-6β-glucuronide antinociception in the rat by antisense oligodeoxynucleotides against MOR-1. J Pharmacol Exp Ther 281:109-114.
25. Rossi GC, Pan YX, Brown GP and Pasternak GW (1995a): Antisense mapping the MOR-1 receptor (1995a): evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett 369:192-196.
26. Rossi GC, Pan YX, Cheng J and Pasternak GW (1994): Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor. Life Sci 54:PL375-379.
27. Rossi GC, Perlmutter M, Leventhal L, Talatti A and Pasternak GW (1998): Characterizing orphanin FQ/nociceptin analgesia in the rat through the use of antisense oligodeoxynucleotides. Brain Res 792:327-330.
28. Rossi GC, Su W, Leventhal L, Su H and Pasternak GW (1997b): Antisense mapping DOR-1 in mice: further support for delta receptor subtypes. Brain Res 753:176-179.
29. Rossi GC, Standifer KM and Pasternak GW (1995b): Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett 198:99-102.
30. Sanger DJ and McCarthy PS (1980): Differential effects of morphine on food and water intake in food deprived and freely feeding rats. Psychopharmacy 72:103-106.
31. Schuller AGP, King M, Zhang J, Czick M, Unterwald E, Pasternak GW and Pintar JE (1997): Heroin and M6G analgesia are retained in mu opioid receptor deficient mice. Soc Neurosci Abstr 23:584.
32. Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, Yoshimura H and Tsukamoto H (1971): Analgesic effects of morphine glucuronides. Tokohu J Exp Med 105:45-52.
33. Standifer KM, Rossi GC and Pasternak GW (1996): Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein alpha subunits. Mol Pharmacol 50:293-298.
34. Sullivan AF, McQuay HJ, Bailey D and Dickenson AH (1989) The spinal antinociceptive actions of morphine metabolites, morphine-6β-glucuronide and normorphine in the rat. Brain Res 482:219-224.
35. Thornhill JA, Hirst M and Gowdey CW (1976): Disruption of diurnal feeding patterns of rats by heroin. Pharmacol Biochem Behav 4:129-135.
36. Uhl GR, Childers SR and Pasternak GW (1994): An opiate receptor gene family reunion. Trends Neurosci 17:89-93.
37. Yu W-Z, Ruegg H and Bodnar RJ (1997): Delta and kappa opioid receptor subtypes and ingestion: Antagonist and glucoprivic effects. Pharmacol Biochem Behav 56: 353-361.